← Back to Search

Probiotic

Yogurt with B. lactis and added honey for Stress (NECTAR Trial)

N/A
Waitlist Available
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

NECTAR Trial Summary

This trial will test if adding yogurt with honey to your diet has benefits for digestive health and mood.

Eligible Conditions
  • Gastrointestinal Dysfunction
  • Stress
  • Cognitive Impairment

NECTAR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intestinal transit time measured using colored dye markers
Secondary outcome measures
Cognitive function assessed using the Spatial Reconstruction Task
Digestive health measured using daily stool records with the Bristol Stool Scale
Digestive health measured using rating scales of additional symptoms in daily stool records
+7 more

NECTAR Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Yogurt with B. lactis and added honeyExperimental Treatment1 Intervention
Participants will consume yogurt with B. lactis and added honey twice daily for 14 days.
Group II: Yogurt with inactivated B. lactis and added cane sugarPlacebo Group1 Intervention
Participants will consume yogurt with heat inactivated B. lactis and added cane sugar twice daily for 14 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yogurt with B. lactis and added honey
2021
N/A
~70

Find a Location

Who is running the clinical trial?

National Honey BoardOTHER
3 Previous Clinical Trials
251 Total Patients Enrolled
University of Illinois at Urbana-ChampaignLead Sponsor
192 Previous Clinical Trials
37,422 Total Patients Enrolled
~16 spots leftby Jun 2025